Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

66.7%

2 terminated/withdrawn out of 3 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02325830Not ApplicableCompleted

Carillon Mitral Contour System® for Reducing Functional Mitral Regurgitation

Role: lead

NCT04529928Not ApplicableTerminated

An Initial Evaluation of the Carillon Mitral Contour System for Treatment of Atrial Function Mitral Regurgitation

Role: lead

NCT05040451Withdrawn

Carillon Mitral Contour System for Treatment of Exercise Induced Functional Mitral Regurgitation

Role: lead

All 3 trials loaded